Nov 19 (Reuters) - Canada on Friday said Pfizer (PFE.N) and partner BioNTech (22UAy.DE) COVID-19 vaccine was authorized for use in children aged 5 to 11, making it the first shot for young children in the country. Reporting by Manojna Maddipatla in Bengaluru; Editing by Anil D"Silva
مشاركة :